FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1548897952> ?p ?o ?g. }

• W1548897952 abstract "Background Phosphate binders are widely used to lower serum phosphorus levels in people with chronic kidney disease (CKD) but their impact in CKD remains controversial. Objectives To review the effects of various phosphate binders on biochemical and patient‐level end‐points in CKD stages 3 to 5D. Search methods In March 2010 we searched MEDLINE, EMBASE, the Cochrane Renal Group's Specialised Register and CENTRAL for relevant studies. Selection criteria Randomised controlled trials (RCTs) or quasi‐RCTs that assessed the effects of various phosphate binders in adults with CKD. Data collection and analysis Two authors independently reviewed search results and extracted data. Results were expressed as mean differences (MD) for continuous outcomes and risk ratios (RR) for dichotomous outcomes with 95% confidence intervals (CI) using a random‐effects model. Main results Sixty studies (7631 participants) were included. There was no significant reduction in all‐cause mortality (10 studies, 3079 participants: RR 0.73, 95% CI 0.46 to 1.16), or serum calcium by phosphorus (Ca x P) product with sevelamer hydrochloride compared to calcium‐based agents. There was a significant reduction in serum phosphorus (16 studies, 3126 participants: MD 0.23 mg/dL, 95% CI 0.04 to 0.42) and parathyroid hormone (PTH) (12 studies, 2551 participants; MD 56 pg/mL, 95% CI 26 to 84) but a significant increase in the risk of hypercalcaemia (12 studies, 1144 participants: RR 0.45, 95% CI 0.35 to 0.59) with calcium‐based agents compared to sevelamer hydrochloride. There was a significant increase in the risk of adverse gastrointestinal events with sevelamer hydrochloride in comparison to calcium salts (5 studies, 498 participants: RR 1.58, 95% CI 1.11 to 2.25). Compared with calcium‐based agents, lanthanum significantly reduced serum calcium (2 studies, 122 participants: MD ‐0.30 mg/dL, 95% CI ‐0.64 to ‐0.25) and the Ca x P product, but not serum phosphorus levels. The effects of calcium acetate on biochemical end‐points were similar to those of calcium carbonate. The phosphorus lowering effects of novel agents such as ferric citrate, colestilan and niacinamide were only reported in a few studies. Authors' conclusions Available phosphate‐binding agents have been shown to reduce phosphorus levels in comparison to placebo. However, there are insufficient data to establish the comparative superiority of novel non‐calcium binding agents over calcium‐containing phosphate binders for patient‐level outcomes such as all‐cause mortality and cardiovascular end‐points in CKD." @default.
• W1548897952 created "2016-06-24" @default.
• W1548897952 creator A5018429053 @default.
• W1548897952 creator A5025398073 @default.
• W1548897952 creator A5035786059 @default.
• W1548897952 creator A5038938109 @default.
• W1548897952 creator A5065654610 @default.
• W1548897952 creator A5088788555 @default.
• W1548897952 date "2011-02-16" @default.
• W1548897952 modified "2023-10-14" @default.
• W1548897952 title "Phosphate binders for preventing and treating bone disease in chronic kidney disease patients" @default.
• W1548897952 cites W1598602811 @default.
• W1548897952 cites W1920183215 @default.
• W1548897952 cites W1966419427 @default.
• W1548897952 cites W1967759185 @default.
• W1548897952 cites W1971987375 @default.
• W1548897952 cites W1973733126 @default.
• W1548897952 cites W1978473272 @default.
• W1548897952 cites W1979374558 @default.
• W1548897952 cites W1979587730 @default.
• W1548897952 cites W1986228231 @default.
• W1548897952 cites W1986364725 @default.
• W1548897952 cites W1990734350 @default.
• W1548897952 cites W1993380941 @default.
• W1548897952 cites W1995142379 @default.
• W1548897952 cites W1997768246 @default.
• W1548897952 cites W2000331944 @default.
• W1548897952 cites W2003534875 @default.
• W1548897952 cites W2005233296 @default.
• W1548897952 cites W2007026031 @default.
• W1548897952 cites W2009081188 @default.
• W1548897952 cites W2010031754 @default.
• W1548897952 cites W2010549227 @default.
• W1548897952 cites W2011587556 @default.
• W1548897952 cites W2013706974 @default.
• W1548897952 cites W2015764854 @default.
• W1548897952 cites W2020010772 @default.
• W1548897952 cites W2020300640 @default.
• W1548897952 cites W2021908911 @default.
• W1548897952 cites W2023653442 @default.
• W1548897952 cites W2025260872 @default.
• W1548897952 cites W2026420466 @default.
• W1548897952 cites W2026531757 @default.
• W1548897952 cites W2030174339 @default.
• W1548897952 cites W2031331198 @default.
• W1548897952 cites W2032018549 @default.
• W1548897952 cites W2032667713 @default.
• W1548897952 cites W2033089817 @default.
• W1548897952 cites W2037687164 @default.
• W1548897952 cites W2038550793 @default.
• W1548897952 cites W2045847718 @default.
• W1548897952 cites W2050568826 @default.
• W1548897952 cites W2052472016 @default.
• W1548897952 cites W2055075230 @default.
• W1548897952 cites W2060235898 @default.
• W1548897952 cites W2061056576 @default.
• W1548897952 cites W2067702617 @default.
• W1548897952 cites W2069942555 @default.
• W1548897952 cites W2073731863 @default.
• W1548897952 cites W2073967243 @default.
• W1548897952 cites W2076634792 @default.
• W1548897952 cites W2076944326 @default.
• W1548897952 cites W2081260553 @default.
• W1548897952 cites W2084088491 @default.
• W1548897952 cites W2092567657 @default.
• W1548897952 cites W2092787493 @default.
• W1548897952 cites W2094710838 @default.
• W1548897952 cites W2096549618 @default.
• W1548897952 cites W2103233315 @default.
• W1548897952 cites W2105024958 @default.
• W1548897952 cites W2106504544 @default.
• W1548897952 cites W2107207648 @default.
• W1548897952 cites W2107328434 @default.
• W1548897952 cites W2112045675 @default.
• W1548897952 cites W2113881037 @default.
• W1548897952 cites W2114203325 @default.
• W1548897952 cites W2114543897 @default.
• W1548897952 cites W2117231861 @default.
• W1548897952 cites W2118308161 @default.
• W1548897952 cites W2122037712 @default.
• W1548897952 cites W2124252987 @default.
• W1548897952 cites W2125435699 @default.
• W1548897952 cites W2125836953 @default.
• W1548897952 cites W2131599914 @default.
• W1548897952 cites W2132700529 @default.
• W1548897952 cites W2135193138 @default.
• W1548897952 cites W2138247546 @default.
• W1548897952 cites W2145887393 @default.
• W1548897952 cites W2146253223 @default.
• W1548897952 cites W2149233919 @default.
• W1548897952 cites W2156017558 @default.
• W1548897952 cites W2160919161 @default.
• W1548897952 cites W2162430779 @default.
• W1548897952 cites W2167672464 @default.
• W1548897952 cites W2170092490 @default.
• W1548897952 cites W2320920680 @default.
• W1548897952 cites W2330058697 @default.
• W1548897952 cites W2333627066 @default.
• W1548897952 cites W4248615287 @default.
• W1548897952 doi "https://doi.org/10.1002/14651858.cd006023.pub2" @default.

• next